Patent ID: 9629848
Date: 2017-04-25
CPC Classifications: A61K

Claim:
1. A method of preventing, treating or ameliorating autoimmune diabetes by administering to a mammal in need of such treatment, a therapeutically effective amount of a compound selected from the group consisting of: 1,3,6,8-tetraazatricyclo[4.4.1.1(3,8)]dodecane, 1-ethyl-15,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decane, 1-allyl-15,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decane, 1-(15,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]dec-1-yl)acetone, 1-(2,4,5-trichlorobenzyl)-15,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decane, 1-bromo-15,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decane, 2-(15,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]dec-1-yl)ethanol, 1-(4-chloro-2-butenyl)-15,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decane, 1-(2-chloro-2-propenyl)-15,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decane, 1-benzyl-15,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decane, 1-(2,3-dibromo-2-propenyl)-15,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decane, 1-(3-chloro-2-propenyl)-15,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decane, and 1-(2-oxiranylmethyl)-15,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decane, and pharmaceutically-acceptable salts thereof.